Liver cancer in Hidalgo State, Mexico
analysis of the status, risk factors and regional public health policy requirements: a cross-sectional correlational study
Keywords:
Alcoholism, Health policy, Liver neoplasms, Regional medical programs, Risk factors, Public healthAbstract
BACKGROUND: In Latin America, liver cancer is one of the top causes of cancer mortality. It is the fifth most common cause of death among malignant tumors in Mexico and is the leading cause in Hidalgo State (43.8% of the population living in poverty). OBJECTIVE: To conduct a correlational analysis on the main risk factors for liver cancer in Hidalgo State, Mexico, including municipal disaggregation and comparison with the national level. DESIGN AND SETTING: Cross-sectional, correlational, descriptive and comparative epidemiological study using Mexican governmental databases covering 1990-2019. METHODS: A comprehensive review of the databases of the General Directorate of Health Information (DGIS) was performed to analyze official death figures, hospital discharges and national and municipal population projections, using specific search criteria defined in the Global Burden of Disease classification, based on the risk factors for liver cancer. RESULTS: Liver cancer rates showed an evident rise in Hidalgo (183%), moving from 21st place in Mexico in 1990 to 9th place in 2019. This increase was correlated with alcoholism. An increasing trend for liver cancer deaths, of 133.89%, is projected for 2030. Females and the population over 60 years of age are more affected. There are some critical regions with liver cancer death rates twice the national rate or more. CONCLUSION: Targeted effective public health strategies should be structured by identifying, characterizing and regionalizing critical marginalized municipalities that are vulnerable to alcoholism and other risk factors for liver cancer. This approach may be helpful for other states in Mexico or similar countries.BACKGROUND: In Latin America, liver cancer is one of the top causes of cancer mortality. It is the fifth most common cause of death among malignant tumors in Mexico and is the leading cause in Hidalgo State (43.8% of the population living in poverty). OBJECTIVE: To conduct a correlational analysis on the main risk factors for liver cancer in Hidalgo State, Mexico, including municipal disaggregation and comparison with the national level. DESIGN AND SETTING: Cross-sectional, correlational, descriptive and comparative epidemiological study using Mexican governmental databases covering 1990-2019. METHODS: A comprehensive review of the databases of the General Directorate of Health Information (DGIS) was performed to analyze official death figures, hospital discharges and national and municipal population projections, using specific search criteria defined in the Global Burden of Disease classification, based on the risk factors for liver cancer. RESULTS: Liver cancer rates showed an evident rise in Hidalgo (183%), moving from 21st place in Mexico in 1990 to 9th place in 2019. This increase was correlated with alcoholism. An increasing trend for liver cancer deaths, of 133.89%, is projected for 2030. Females and the population over 60 years of age are more affected. There are some critical regions with liver cancer death rates twice the national rate or more. CONCLUSION: Targeted effective public health strategies should be structured by identifying, characterizing and regionalizing critical marginalized municipalities that are vulnerable to alcoholism and other risk factors for liver cancer. This approach may be helpful for other states in Mexico or similar countries.
Downloads
References
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. PMID: 33538338; https://doi.org/10.3322/caac.21660.
Piñero F, Poniachik J, Ridruejo E, Silva M. Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges. World J Gastroenterol. 2018;24(37):4224-9. PMID: 30310255; https://doi.org/10.3748/wjg.v24.i37.4224.
Galicia-Moreno M, Monroy-Ramirez HC, Campos-Valdez M, et al. Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology, diagnosis and treatment. Hepatoma Res. 2020;6:20. https://doi.org/10.20517/2394-5079.2019.36.
Carrilho FJ, Paranaguá-Vezozzo DC, Chagas AL, Alencar RSSM, da Fonseca LG. Epidemiology of liver cancer in Latin America: Current and future trends. Semin Liver Dis. 2020;40(2):101-10. PMID: 31711252; https://doi.org/10.1055/s-0039-3399561.
Castells Fusté L. Virus de la hepatitis B y carcinoma hepatocelular. Gastroenterol Hepatol. 2006;29:86-92. https://doi.org/10.1157/13097585.
Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013;47 Suppl(0):S2-S6. PMID: 23632345; https://doi.org/10.1097/MCG.0b013e3182872f29.
Méndez-Sánchez N, Villa AR, Vázquez-Elizondo G, Ponciano-Rodríguez G, Uribe M. Mortality trends for liver cancer in Mexico from 2000 to 2006. Ann Hepatol. 2008;7(3):226-9. PMID: 18753989; https://doi.org/10.1016/S1665-2681(19)31852-6.
Cisneros-Garza LE, González-Huezo MS, López-Cossio JA, Kuljacha-Gastelum AL. Characterization of hepatocellular carcinoma in Mexico. Rev Gastroenterol Mex. 2018;83(3):223-7. PMID: 29801665; https://doi.org/10.1016/j.rgmx.2017.06.003.
Méndez-Sánchez N, Villa AR, Chávez-Tapia NC, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005;4(1):52-5. PMID: 15798662; https://doi.org/10.1016/S1665-2681(19)32086-1.
González-Huezo MS, Sánchez-Ávila JF. Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Rev Gastroenterol Mex. 2014;79(4):250-62. PMID: 25487133; https://doi.org/10.1016/j.rgmx.2014.09.004.
DataMéxico: Hidalgo entidad federativa. Datawheel. 2021. Available from: Available from: https://datamexico.org/es/profile/geo/hidalgo-hg Accessed in 2021 (Nov 19).
World Health Organization. International Agency for Research on Cancer; 2020. Available from: Available from: https://gco.iarc.fr/ Accessed in 2021 (Nov 19).
Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, et al. Las enfermedades crónicas no transmisibles en México: sinopsis epidemiológica y prevención integral [Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention]. Salud Publica Mex. 2008;50(5):419-27. PMID: 18852939; https://doi.org/10.1590/s0036-36342008000500015.
Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010;42 Suppl 3(Suppl 3):S206-14. https://doi.org/10.1016/s1590-8658(10)60507-5.
Roman S, Zepeda-Carrillo EA, Moreno-Luna LE, Panduro A. Alcoholism and liver disease in Mexico: genetic and environmental factors. World J Gastroenterol. 2013;19(44):7972-82. https://doi.org/10.3748/wjg.v19.i44.7972.
Schoenman JA, Sutton JP, Elixhauser A, Love D. Understanding and enhancing the value of hospital discharge data. Med Care Res Rev. 2007;64(4):449-68. PMID: 17684112; https://doi.org/10.1177/1077558707301963.
Fajardo González M, Arce Nuñez M, Medina Garrido Y, Esteva Carral L, Osorio Pagola M. Comportamiento de la cirrosis hepática en el hospital “Arnaldo Milián Castro” de julio de 2007 a marzo de 2009. MediSur. 2010;8:40-8. Available from: Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2010000400007&lng=es&nrm=iso&tlng=es Accessed in 2021 (Nov 19).
Valdespino J, Conde-González C, Olaiz-Fernández G. Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? [Seroprevalence of hepatitis C among Mexican adults: an emerging public health problem?]. Salud Publica Mex. 2007;49(3):395-403. Available from: Available from: https://scielosp.org/article/spm/2007.v49suppl3/s395-s403/es/#ModalArticles Accessed in 2021 (Nov 19).
Sedeño-Monge V, Laguna-Meraz S, Santos-López G, et al. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico-A systematic review and meta-analysis (2008-2019). Ann Hepatol. 2021;20:100292. PMID: 33259949; https://doi.org/10.1016/j.aohep.2020.100292.
Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019;70(2):284-93. PMID: 30658729; https://doi.org/10.1016/j.jhep.2018.10.008.
González-Bautista E, Zavala-Arciniega L, Rivera-Rivera L, Leyva-López A, Natera-Rey G, Reynales-Shigematsu LM. Factores sociales asociados con el consumo de tabaco y alcohol en adolescentes mexicanos de poblaciones menores a 100 000 habitantes [Social factors associated with tobacco and alcohol consumption in Mexican adolescents from populations under 100 000 inhabitants.]. Salud Publica Mex. 2019;61(6):764-74. PMID: 31869541; https://doi.org/10.21149/10563.
CIJ. Estudio básico de comunidad objetivo 2018: Diagnóstico del consumo de drogas del área de influencia del CIJ Pachuca, Hidalgo. 2018 ed: Centros de Integración Juvenil; 2018. p. 1-9. Available from: Available from: http://www.cij.gob.mx/ebco2018-2024/9010/CD/9010_CD_Dx.pdf Accessed in 2021 (Nov 19).
CONADIC. Informe sobre la situación de la salud mental y el consumo de sustancias psicoactivas en México. In: SSA, editor. Mexico: Comisión Nacional Contra las Adicciones; 2021. p. 1-63. Available from: Available from: https://www.gob.mx/cms/uploads/attachment/file/648021/INFORME_PAIS_2021.pdf Accessed in 2021 (Nov 19).
Magis-Rodríguez C, García-Sánchez JA, Marín-Navarrete R. Harm reduction among people who inject drugs in Mexico. Salud Mental. 2018;41(4):153-6. https://doi.org/10.17711/sm.0185-3325.2018.023.
CONEVAL. Pobreza Municipal: Hidalgo Mexico: CONEVAL; 2018. Available from: Available from: https://www.coneval.org.mx/coordinacion/entidades/Hidalgo/Paginas/principal.aspx Accessed in 2021 (Nov 19).
Machado CV, Lima LD. Health policies and systems in Latin America: regional identity and national singularities. Cad Saude Publica. 2017;33Suppl 2 (Suppl 2):e00068617. PMID: 28767811; https://doi.org/10.1590/0102-311X00068617.
Bishai DM, Frattaroli S, Pollack KM. Public health policies: Go local! Am J Public Health. 2017;107(5):672-4. PMID: 28398793; https://doi.org/10.2105/AJPH.2017.303682.
Lazcano-Ponce E, Mohar-Betancourt A, Meneses-García A, Hernández-Ávila M. Cancer burden in Mexico: urgent challenges to be met. Salud Publica Mex. 2016;58(2):101-3. PMID: 27557368; http://doi.org/10.21149/spm.v58i2.7778.
Leal YA, Fernández-Garrote LM, Mohar-Betancourt A, Meneses-García A. The importance of registries in cancer control. Salud Publica Mex. 2016;58(2):309-16. PMID: 27557391; http://doi.org/10.21149/spm.v58i2.7802.
